Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/41797
Title: Plasma branched chain/aromatic amino acids, enriched Mediterranean diet and risk of type 2 diabetes: case-cohort study within the PREDIMED Trial
Authors: Ruiz-Canela, Miguel
Guasch-Ferre, Marta 
Toledo, Estefania
Clish, Clary B.
Razquin, Cristina
Liang, Liming
Wang, Dong D.
Corella, Dolores
Estruch, Ramon
Hernaez, Alvaro
Yu, Edward
Gomez-Gracia, Enrique
Zheng, Yan
Aros, Fernando
Romaguera, Dora
Dennis, Courtney
Ros, Emilio
Lapetra, Jose
Serra-Majem, Lluis 
Papandreou, Christopher
Portoles, Olga
Fito, Montserrat
Salas-Salvado, Jordi
Hu, Frank B.
Martinez-Gonzalez, Miguel A.
UNESCO Clasification: 3206 Ciencias de la nutrición
Keywords: Aromatic amino acids
Branched-chain amino acids
Mediterranean diet
Type 2 diabetes
Issue Date: 2018
Journal: Diabetologia (Berlin) 
Abstract: Aims/hypothesis Branched-chain amino acids (BCAAs) and aromatic amino acids (AAAs) are associated with type 2 diabetes. However, repeated measurements of BCAA/AAA and their interactions with dietary interventions have not been evaluated. We investigated the associations between baseline and changes at 1 year in BCAA/AAA with type 2 diabetes in the context of a Mediterranean diet (MedDiet) trial. Methods We included 251 participants with incident type 2 diabetes and a random sample of 694 participants (641 participants without type 2 diabetes and 53 overlapping cases) in a case-cohort study nested within the PREvención con DIeta MEDiterránea (PREDIMED) trial. Participants were randomised to a MedDiet+extra-virgin olive oil (n = 273), a MedDiet+nuts (n = 324) or a control diet (n = 295). We used LC-MS/MS to measure plasma levels of amino acids. Type 2 diabetes was a pre-specified secondary outcome of the PREDIMED trial. Results Elevated plasma levels of individual BCAAs/AAAs were associated with higher type 2 diabetes risk after a median follow-up of 3.8 years: multivariable HR for the highest vs lowest quartile ranged from 1.32 for phenylalanine ([95% CI 0.90, 1.92], p for trend = 0.015) to 3.29 for leucine ([95% CI 2.03, 5.34], p for trend<0.001). Increases in BCAA score at 1 year were associated with higher type 2 diabetes risk in the control group with HR per SD = 1.61 (95% CI 1.02, 2.54), but not in the MedDiet groups (p for interaction <0.001). The MedDiet+extra-virgin olive oil significantly reduced BCAA levels after 1 year of intervention (p = 0.005 vs the control group). Conclusions/interpretation Our results support that higher baseline BCAAs and their increases at 1 year were associated with higher type 2 diabetes risk. A Mediterranean diet rich in extra-virgin olive oil significantly reduced the levels of BCAA and attenuated the positive association between plasma BCAA levels and type 2 diabetes incidence.
URI: http://hdl.handle.net/10553/41797
ISSN: 0012-186X
DOI: 10.1007/s00125-018-4611-5
Source: Diabetología [ISSN 0012-186X], v. 61 (7), p. 1560-1571
Appears in Collections:Artículos
Show full item record

SCOPUSTM   
Citations

26
checked on Oct 18, 2020

Page view(s)

21
checked on Oct 18, 2020

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.